Primary aldosteronism is a specifically treatable and potentially curable form of secondary
hypertension. The aldosterone/plasma renin activity ratio (ARR) is routinely used as a …

Background While both renin‐dependent and renin‐independent aldosterone secretion
contribute to aldosteronism, their relative associations with cardiovascular disease (CVD) …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, improved screening methods show that primary aldosteronism is a …

A growing body of evidence suggests that hyperaldosteronism contributes significantly to the
development and the severity of hypertension as well as to resistance to antihypertensive …

Context While current guidelines recommend the withdrawal of mineralocorticoid receptor
antagonist (MRA) and renin-angiotensin system blockers for the screening and detection of …

The prevalence of primary aldosteronism (PA) was assessed in a specialized hypertension
center. Baseline and postcaptopril (50 mg orally) aldosterone to plasma renin activity ratio …

Primary aldosteronism is recognized as the most frequent cause of secondary hypertension,
and its screening is expected to become a routine evaluation in most patients with …

Aldosterone: renin ratio (ARR) is used to screen for hyperaldosteronism. Data regarding
correlates of ambulatory ARR in the community and its relation to hypertension incidence …

Objective: Up to 50% of hypertensive patients should be screened for primary
aldosteronism, using the aldosterone to renin (or plasma renin activity) ratio [aldosterone to …

Background Current guidelines recommend use of the aldosterone‐renin ratio (ARR) for the
case detection of primary aldosteronism followed by confirmatory tests to exclude false …